Stay updated on AV-101 for Levodopa Dyskinesia: PD Clinical Trial
Sign up to get notified when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.

Latest updates to the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference2%
- Check50 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check64 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check71 days agoChange DetectedThe website has updated the intervention type information to include a verified status by VistaGen Therapeutics, Inc. from May 2021, while also revising the version from v2.13.3 to v2.14.0.SummaryDifference1%
- Check100 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
Stay in the know with updates to AV-101 for Levodopa Dyskinesia: PD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.